tirzepatide isn't working anymore Why Am I Not Losing Weight On 7 Reasons You Aren't Losing

Some patients may potentially increase consumption of acidic beverages, sugary drinks, or frequent small snacks to manage nausea or maintain adequate nutrition despite reduced appetite

The launch of generic liraglutide (Teva, August 2025) and anticipated oral GLP-1 options (oral Wegovy approved December 2025, orforglipron pending) offer lower-cost alternatives that may simplify pharmacy benefit management

This may suggest additional benefits, as research associates 510% weight loss with a reduced risk of heart disease and type 2 diabetes. Long-term, it may not be sustainable Optavia may bring quick results

It acts in a more subtle manner by altering the way your body holds onto and distributes fat